Compare Acset Indonusa Tbk (ACST) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acset Indonusa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Acset Indonusa Tbk trades at Rp87 (market cap 1.52T, 161.8K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Acset Indonusa Tbk is far larger — about 2.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 161.8K). Which is the better fit depends on your goals.
| ACST | LABS | |
|---|---|---|
Market Cap | 1.52T | 635.95B |
Volume | 161.8K | 843K |
Lot | 1.62K | 8.43K |
Turnover | 14.08M | 137.6M |
Average Price | 87.04 | 163.22 |
Value | 14.08M | 137.6M |
Indicative Equilibrium Price | 87 | 165 |
Indicative Equilibrium Volume | 744 | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acset Indonusa Tbk
PT Acset Indonusa Tbk (the Company) was establised based on Notarial Deed No.2 dated January 10, 1995 of Ny. Liliana Arif Gondoutomo, S.H., Notary in Bekasi.
Read more on ACST →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
